{"gene":"DACH1","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":2003,"finding":"DACH1 binds endogenous NCoR and Smad4 in cultured cells and co-localizes with NCoR in nuclear dot-like structures; the DS domain of DACH1 is sufficient for NCoR binding at a Smad4-binding site, and DACH1 repression of TGF-β-induced AP-1 and Smad signaling requires the DS domain and Smad4.","method":"Co-immunoprecipitation of endogenous proteins, co-localization by immunofluorescence, gene reporter assays, microarray analysis of endogenous TGF-β target genes, Smad4-null cell rescue experiments","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP of endogenous proteins, co-localization, domain mapping, reporter assays, and epistasis in Smad4-null cells; multiple orthogonal methods in a single study","pmids":["14525983"],"is_preprint":false},{"year":2002,"finding":"DACH1 (Dach) binds chromatin DNA directly through its conserved DD1 domain; it does not interact directly with Eya but synergizes with Eya to recruit CBP to chromatin, activating transcription via a Six-Eya-Dach complex.","method":"GST pulldown, GAL4-reporter transactivation assays, chromatin-binding assay with FLAG-Dach and GAL4-Eya fusion proteins, CBP recruitment measured on immobilized chromatin DNA template","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro chromatin-binding reconstitution, domain mapping (DD1), reporter assays, and CBP recruitment assay; multiple orthogonal methods in one study","pmids":["12215533"],"is_preprint":false},{"year":2003,"finding":"Eya phosphatase activity switches Six1-DACH complexes from transcriptional repression to activation; DACH participates in this switch by recruiting co-activators when Eya phosphatase is present, regulating precursor cell proliferation in organogenesis.","method":"Genetic interaction studies in mice (Six1 knockout, Eya compound mutants), transcriptional reporter assays, co-immunoprecipitation, Eya phosphatase activity assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — enzymatic assay establishing Eya phosphatase activity, genetic epistasis in mice, reporter assays; replicated across multiple organ systems in one rigorous study","pmids":["14628042"],"is_preprint":false},{"year":2006,"finding":"DACH1 represses cyclin D1 transcription through a c-Jun DNA-binding partner; the DS domain recruits corepressors to local chromatin. Genetic deletion studies demonstrated a requirement for cyclin D1 in DACH1-mediated inhibition of DNA synthesis, and DACH1 inhibited breast tumor growth in mice.","method":"Chromatin immunoprecipitation, reporter assays, cyclin D1 knockout rescue experiments, colony formation/Matrigel growth assays, xenograft tumor growth in mice","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP, genetic rescue with cyclin D1 deletion, in vivo tumor model, reporter assays; multiple orthogonal methods","pmids":["16980615"],"is_preprint":false},{"year":2006,"finding":"DACH1 binds c-Jun and inhibits AP-1 transcriptional activity; it coprecipitates HDAC1, HDAC2, and NCoR and represses c-Jun target genes through the c-Jun delta domain in a manner requiring the conserved DS domain. An oncogenic v-Jun deleted of the delta domain is resistant to DACH1 repression.","method":"Co-immunoprecipitation, reporter assays, Cre-mediated c-jun excision in c-jun(fl/fl) cells (epistasis), c-jun rescue of DACH1 inhibition, domain deletion mutagenesis","journal":"Molecular Biology of the Cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, genetic epistasis (Cre excision of c-jun), domain mutagenesis, and reporter assays; multiple orthogonal methods","pmids":["17182846"],"is_preprint":false},{"year":2009,"finding":"DACH1 binds ERα by co-immunoprecipitation and co-associates with ERα at endogenous ER response elements by ChIP; it inhibits ERα transcriptional activity requiring the conserved DS domain. PELP1 was identified as a DACH1 C-terminus binding protein by proteomics; estrogen recruits ERα and disengages corepressors from DACH1, allowing PELP1 to serve as ERα coactivator.","method":"Co-immunoprecipitation/Western blot, chromatin immunoprecipitation, reporter assays, proteomic identification of PELP1, domain deletion mutagenesis","journal":"Cancer Research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, ChIP at endogenous loci, proteomic identification of binding partner, domain mapping; multiple orthogonal methods in one study","pmids":["19605405"],"is_preprint":false},{"year":2010,"finding":"DACH1 binds a DNA sequence resembling the FOX (Forkhead) binding site identified by CAST; genome-wide ChIP-seq confirmed DACH1 occupancy at FOX-like elements. DACH1 antagonized FOXM1 target gene expression and promoter occupancy in chromatin, blocking contact-independent growth.","method":"Cyclic amplification and selection of targets (CAST), in silico promoter analysis, ChIP coupled with high-throughput sequencing (ChIP-seq), promoter occupancy assays, colony formation assay","journal":"Proceedings of the National Academy of Sciences of the USA","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — CAST to define binding sequence, genome-wide ChIP-seq, functional reporter and growth assays; multiple rigorous orthogonal methods","pmids":["20351289"],"is_preprint":false},{"year":2013,"finding":"DACH1 suppresses EMT by repressing cytoplasmic translational induction of Snail through inactivating YB-1, and in the nucleus DACH1 antagonizes YB-1-mediated oncogenic transcriptional modules; DACH1 blocked YB-1-induced mammary tumor growth and EMT in mice.","method":"Co-immunoprecipitation, reporter assays, in vivo mammary tumor model, knockdown/overexpression studies","journal":"Cancer Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, in vivo tumor model, dual nuclear/cytoplasmic mechanism; single lab but multiple approaches","pmids":["24335958"],"is_preprint":false},{"year":2015,"finding":"DACH1 physically interacts with SNAI1 (but not SNAI2) and forms a complex that binds the E-box on the E-cadherin promoter in an SNAI1-dependent manner; this complex inhibits SNAI1 transcriptional activity, resulting in E-cadherin activation and suppression of breast cancer EMT and metastasis.","method":"Co-immunoprecipitation, chromatin immunoprecipitation at E-cadherin E-box, reporter assays, loss/gain-of-function experiments, mouse metastasis model","journal":"Oncogenesis","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP, ChIP at endogenous promoter, reporter assays, in vivo metastasis model; multiple orthogonal methods","pmids":["25775416"],"is_preprint":false},{"year":2004,"finding":"Chick Dach1 interacts with the Smad complex and Sin3a corepressor to repress BMP-mediated transcription; this antagonism regulates AER formation and limb proximodistal patterning.","method":"Co-immunoprecipitation (Dach1-Smad complex and Sin3a), in vivo gain/loss-of-function in chick limb, reporter assays","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP, in vivo chick limb manipulations, reporter assays; ortholog paper with consistent domain function","pmids":["15280207"],"is_preprint":false},{"year":2016,"finding":"In obesity, CaMKII phosphorylates HDAC4 blocking its nuclear translocation; this decreases HDAC4-mediated SUMOylation of DACH1, protecting DACH1 from proteasomal degradation. Stabilized DACH1 then co-represses ATF6 transcription together with NCOR, leading to PERK-TRB3 pathway activation and defective hepatocyte insulin signaling.","method":"Co-immunoprecipitation (DACH1-NCOR complex), SUMOylation assay, HDAC4 nuclear translocation assay, shRNA knockdown in liver (hepatocyte-specific), obese mouse model rescue experiments, Western blot","journal":"Cell Reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple biochemical assays (Co-IP, SUMOylation, phosphorylation), in vivo liver-targeted shRNA rescue, mechanistic pathway placed by epistasis; rigorous multimethod study","pmids":["27239042"],"is_preprint":false},{"year":2018,"finding":"DACH1 represses ATF6 transcription in hepatocytes (together with NCOR), controlling hepatocyte-derived tPA and basal plasma tPA/fibrinolytic activity; hepatocyte-DACH1-knockout mice show increased liver Plat, circulating tPA, and altered coagulation parameters reversed by hepatocyte Plat silencing.","method":"Hepatocyte-specific DACH1 knockout mice, co-repressor assays, liver Plat/tPA measurements, bleeding/thrombosis time assays, hepatocyte-ATF6 knockout comparison","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — liver-specific KO with multiple in vivo functional readouts, pathway epistasis (DACH1→ATF6→Plat), reversal by Plat silencing","pmids":["30504459"],"is_preprint":false},{"year":2011,"finding":"DACH1 transcriptionally represses FGF2/bFGF; ChIP confirmed DACH1 binding at the FGF2 locus in serum-free glioma cells. Exogenous bFGF rescued spheroid-forming activity and tumorigenicity of DACH1-high glioma cells, placing DACH1 upstream of FGF2 in control of tumor-initiating cell activity.","method":"Chromatin immunoprecipitation, gene expression analysis, inducible DACH1 expression system (doxycycline-regulated), exogenous bFGF rescue, in vivo subcutaneous xenograft","journal":"Proceedings of the National Academy of Sciences of the USA","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP, inducible expression with dox, in vivo xenograft, bFGF rescue experiment; multiple orthogonal methods","pmids":["21750150"],"is_preprint":false},{"year":2017,"finding":"Endothelial DACH1 stimulates CXCL12 expression and endothelial cell polarization/migration against flow; loss of Dach1 in endothelium resulted in small coronary arteries and reduced CXCR4-dependent cell migration. High uniform laminar shear stress down-regulates DACH1 while low variable flow maintains it, linking flow quality to artery growth.","method":"Endothelial-specific Dach1 knockout mice (in vivo coronary artery morphometry), DACH1 overexpression under shear stress in culture, CXCL12/CXCR4 pharmacological inhibition rescue, flow cytometry, immunofluorescence","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — endothelial-specific KO with coronary phenotype, in vitro shear stress assay with pharmacologic rescue of CXCR4; multiple orthogonal methods","pmids":["28779009"],"is_preprint":false},{"year":2021,"finding":"DACH1 controls kidney tubule cell-cycle and myeloid chemotactic factor expression; tubule-specific Dach1 deletion caused more severe renal fibrosis in multiple injury models, while overexpression was protective. DACH1 interacts with PTIP (a component of the H3K4Me3 complex) and recruits it to DACH1-bound promoters, repressing target gene transcription and reducing promoter H3K4Me3 levels.","method":"Tubule-specific Dach1 KO and overexpression mouse models, single-cell RNA-seq, chromatin immunoprecipitation (ChIP for DACH1 and H3K4Me3), CRISPR-Cas9 gene editing of GWAS risk variants, in silico promoter analysis, PTIP co-immunoprecipitation","journal":"The Journal of Clinical Investigation","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — tissue-specific KO and OE with functional rescue, ChIP for DACH1 binding and H3K4Me3, Co-IP of PTIP-DACH1, CRISPR editing; multiple orthogonal rigorous methods","pmids":["33998598"],"is_preprint":false},{"year":2021,"finding":"Podocyte-specific DACH1 interacts with PTIP (an H3K4Me3 complex component) and recruits it to promoter-binding sites, repressing transcription and reducing H3K4Me3 at target promoters; DACH1 knockdown combined with hyperglycemia triggers target gene upregulation and increased promoter H3K4Me3. Podocyte-specific Dach1 KO mice develop accelerated injury after diabetes onset while DACH1 augmentation is protective.","method":"Podocyte-specific Dach1 KO and overexpression mice, RNA-seq, ChIP (H3K4Me3), Co-IP of PTIP-DACH1, high-throughput in silico promoter analysis, diabetic kidney disease models","journal":"The Journal of Clinical Investigation","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — cell-type specific KO and OE with disease phenotype, ChIP, Co-IP, multi-model validation; highly rigorous","pmids":["33998601"],"is_preprint":false},{"year":2012,"finding":"DACH1 regulates cell cycle progression in myeloid progenitor cells: forced DACH1 expression induced p27(Kip1) and repressed p21(Cip1), increased cyclin D1/D3/F and Cdk 1/4/6 expression; DACH1 knockdown blocked HL-60 cell cycle progression through decrease of cyclins/Cdks, increase of p21(Cip1), and reduced Rb phosphorylation.","method":"Forced expression and shRNA knockdown in myeloid progenitor/HL-60 cells, Western blot for cell cycle proteins, Rb phosphorylation assay","journal":"Biochemical and Biophysical Research Communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — gain and loss-of-function with consistent downstream readouts; single lab, Western blot-based","pmids":["22405764"],"is_preprint":false},{"year":2012,"finding":"An endogenous HOXA9-DACH1 complex is mediated by the carboxyl terminus of DACH1 in t(9;11) leukemia cells; DACH1 has stronger transcription-promoting activity with HOXA9 than does PBX2 with HOXA9; C/EBPα and GATA-1 directly bind the DACH1 promoter and act as transcriptional suppressors of DACH1.","method":"Co-immunoprecipitation of endogenous HOXA9-DACH1, qRT-PCR, chromatin occupancy of C/EBPα/GATA-1 at DACH1 promoter, domain mapping (DACH1 carboxyl terminus), ectopic expression experiments","journal":"Biochemical and Biophysical Research Communications","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — endogenous Co-IP, promoter-binding evidence, functional expression experiments; single lab","pmids":["22902925"],"is_preprint":false},{"year":2018,"finding":"DACH1 inhibits the transcription of MMP9 by interacting with p65 and c-Jun at NF-κB and AP-1 binding sites in the MMP9 promoter; DACH1-p65 association promotes recruitment of HDAC1 to the NF-κB site, reducing p65 acetylation and transcriptional activity, thereby decreasing MMP9 levels and breast cancer cell invasion.","method":"Co-immunoprecipitation (DACH1-p65, DACH1-c-Jun), chromatin immunoprecipitation at MMP9 promoter NF-κB/AP-1 sites, HDAC1 recruitment assay, p65 acetylation assay, invasion assays","journal":"Cell Death Discovery","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple Co-IPs, ChIP at endogenous MMP9 promoter, HDAC1 recruitment, p65 acetylation; multiple orthogonal methods in one study","pmids":["34772908"],"is_preprint":false},{"year":2015,"finding":"DACH1 suppresses CXCL5 expression in lung adenocarcinoma cells; there is an inverse correlation between DACH1 mRNA and CXCL5 in lung cancer cell lines and human NSCLC tissues, and functional rescue showed DACH1 effects on invasion are dependent in part on CXCL5 suppression.","method":"Unbiased gene expression screen, qPCR correlation analysis, functional rescue with CXCL5 overexpression, in vitro migration/invasion assays, in vivo tumor xenograft","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — unbiased screen followed by functional CXCL5 rescue; single lab","pmids":["25788272"],"is_preprint":false},{"year":2018,"finding":"Metformin enhances AMPK phosphorylation, which induces DACH1 expression leading to NF-κB inhibition and reduced CXCL1 secretion; DACH1 knockdown blocked the effect of metformin on MDSC chemotaxis, placing DACH1 downstream of AMPK and upstream of CXCL1/NF-κB in this pathway.","method":"Metformin treatment with AMPK/DACH1 knockdown (siRNA epistasis), CXCL1 secretion assay, MDSC migration assay, tumor xenograft in mice with adoptive transfer","journal":"Oncoimmunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway epistasis by siRNA knockdown, in vivo xenograft with adoptive transfer; single lab","pmids":["29900050"],"is_preprint":false},{"year":2013,"finding":"DACH1 suppresses colorectal cancer growth by inhibiting Wnt/TCF-LEF signaling; re-expression of DACH1 reduced TCF/LEF luciferase reporter activity and suppressed Wnt downstream targets c-Myc and cyclin D1. DACH1 re-expression induced G2/M phase arrest and sensitized cells to docetaxel.","method":"TCF/LEF reporter assay, Western blot for c-Myc/cyclin D1, cell cycle analysis (flow cytometry), xenograft tumor model, 5-aza-dC demethylation/re-expression","journal":"Epigenetics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — reporter assays and Western blot with in vivo xenograft; single lab, no direct binding to Wnt components demonstrated","pmids":["24149323"],"is_preprint":false},{"year":2020,"finding":"DACH1 promotes colorectal cancer stem cell properties through suppression of BMP signaling via SMAD4; co-immunoprecipitation demonstrated association between DACH1 and SMAD4; shRNA-mediated DACH1 suppression reduced organoid formation and tumor growth, while DACH1 overexpression stimulated colonsphere formation in the context of dysregulated BMP signaling.","method":"Co-immunoprecipitation (DACH1-SMAD4), CRISPR/Cas9 KO and shRNA knockdown, intestinal organoid model, microarray data analysis, xenotransplant","journal":"EBioMedicine","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP of DACH1-SMAD4, organoid and xenotransplant functional readouts; single lab","pmids":["32512510"],"is_preprint":false},{"year":2018,"finding":"DACH1 and SIX1 co-localize in hepatocellular carcinoma cells; immunoprecipitation shows DACH1 (Flag-tagged) pulls down p53 and SIX1, while SIX1 (His-tagged) pulls down DACH1 but not p53 (indicating SIX1-p53 regulation is indirect through DACH1). DACH1 overexpression suppresses tumorigenesis by up-regulating p53.","method":"Immunoprecipitation (tagged proteins), immunofluorescence co-localization, colony formation assay, nude mice xenograft, Western blot for p53","journal":"Cancer Biology & Therapy","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP with tagged proteins, consistent in vivo xenograft data; single lab, tagged (not endogenous) protein interaction","pmids":["29333942"],"is_preprint":false},{"year":2002,"finding":"Mutations in the EYA domain of Eya1 associated with BOR syndrome (S486P and L504R) show defective interactions with Dach1, G proteins, and some Six proteins by GST pulldown and mammalian two-hybrid assays, implicating direct Eya1-Dach1 protein interaction in normal development.","method":"Mammalian two-hybrid assay, GST pulldown, trypsin/V8 protease digestion pattern analysis, transcriptional activation assay (myogenin promoter)","journal":"Journal of Human Genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — GST pulldown and mammalian two-hybrid showing direct Eya1-Dach1 interaction; disease-linked mutations clarify biological relevance","pmids":["11950062"],"is_preprint":false},{"year":2024,"finding":"DACH1 modulates ferroptosis via the P53/SLC25A37 pathway: ferroptosis inducers increase DACH1 protein by suppressing ubiquitin-proteasome degradation; DACH1 induces p53 phosphorylation at serine 392, causing mitochondrial translocation of p53; mitochondrial p53 binds SLC25A37, enhancing mitochondrial iron uptake and triggering ferroptosis. Mutation of serine 392 prevents DACH1-p53 binding and ferroptosis.","method":"CRISPR-Cas9 DACH1 knockout in hepatic stellate cells, Co-immunoprecipitation (DACH1-p53), pulldown assays, p53 S392A mutagenesis, mitochondrial fractionation, mouse model of hepatic fibrogenesis with HSC-specific knockdowns","journal":"Hepatology Communications","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — CRISPR KO, site-directed mutagenesis (S392A) abolishing DACH1-p53 interaction, Co-IP, subcellular fractionation, in vivo mouse model; multiple orthogonal methods","pmids":["38437058"],"is_preprint":false},{"year":2023,"finding":"Dach1 combined with c-Jun protooncogene selectively binds the promoter of the pro-apoptotic gene Bim, repressing its expression and protecting type II alveolar epithelial cells from apoptosis in pulmonary fibrosis.","method":"Co-immunoprecipitation (DACH1-c-Jun), ChIP at Bim promoter, lung-specific Dach1 overexpression and Dach1 depletion mouse models (BLM-induced PF), in vitro apoptosis assay","journal":"Translational Research","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP and ChIP combined with in vivo lung-specific models; single lab","pmids":["36754276"],"is_preprint":false},{"year":2019,"finding":"DACH1 suppresses EMT and progestin resistance in endometrial carcinoma through Notch1 pathway inhibition via c-Jun; DACH1 overexpression decreased c-Jun, Notch1, and Hes1 expression, and reversed progestin resistance both in vitro and in a xenograft model.","method":"Microarray analysis, gain/loss-of-function with Western blot for Notch1/c-Jun/Hes1, xenograft model, progestin sensitivity assays","journal":"Cancer Medicine","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Western blot pathway analysis, in vivo xenograft; pathway placement by expression/OE/KD; single lab","pmids":["31215145"],"is_preprint":false},{"year":2021,"finding":"siRNA-mediated depletion of DACH1 disrupted primary cilia formation and function in human cells; DACH1 protein localizes to the base of primary cilia as shown by advanced microscopy, revealing a role for DACH1 in ciliogenesis.","method":"siRNA knockdown of DACH1, advanced microscopy imaging (localization at base of cilia), cilia functional assays","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2-3 / Weak — direct localization by imaging and loss-of-function for ciliogenesis; single study, single lab","pmids":["34022343"],"is_preprint":false},{"year":2008,"finding":"Dach1 and Dach2 are redundantly required for Müllerian duct development; Dach1/2 double mutants show severely disrupted female reproductive tract with abnormal Lim1 and Wnt7a expression in the Müllerian duct, while Wolffian duct development is unaffected.","method":"Dach1/Dach2 double homozygous knockout mice, in situ hybridization for Lim1 and Wnt7a in Müllerian duct","journal":"Genesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic double KO with specific reproductive tract phenotype and downstream target analysis; replicates Drosophila dac FRT phenotype","pmids":["18395837"],"is_preprint":false},{"year":2002,"finding":"Fibroblast growth factors (FGF1, 2, 8, 9 but not FGF10) up-regulate Dach1 expression in mouse limb buds while BMP4 down-regulates it; FGF4 or FGF8 can substitute for the apical ectodermal ridge in maintaining Dach1 expression, placing Dach1 as a downstream target of FGF signaling in skeletal development.","method":"FGF-bead implantation in ex vivo mouse limb bud organ culture, BMP4/Shh bead implantation, AER removal with FGF rescue, immunolocalization of Dach1 with Runx2 and CDK inhibitors","journal":"Developmental Dynamics","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — bead implantation in organ culture with multiple growth factors tested; consistent FGF-Dach1 epistasis","pmids":["12203718"],"is_preprint":false}],"current_model":"DACH1 is a transcriptional corepressor/cofactor that lacks autonomous DNA-binding through a sequence-specific domain (the DD1 domain binds chromatin/DNA) and functions through context-dependent complexes: it represses TGF-β/Smad, AP-1 (c-Jun), ERα, FOXM1, NF-κB, Wnt/TCF-LEF, Notch1, BMP/Smad, and Bim transcription by recruiting corepressors (NCoR, HDAC1/2, Sin3a) and by interacting directly with pathway effectors (Smad4, c-Jun, ERα, YB-1, p53, PTIP-H3K4Me3 complex), while its activity as a repressor or activator is switched by Eya phosphatase activity within the Six1-Eya-DACH network; post-translational regulation by HDAC4-mediated SUMOylation and ubiquitin-proteasome degradation controls DACH1 protein stability in metabolic and fibrotic contexts."},"narrative":{"mechanistic_narrative":"DACH1 is a chromatin-associated transcriptional corepressor that constrains proliferation and cell-fate transitions across development, cancer, and tissue injury by docking onto pathway-specific effectors and delivering corepressor machinery to target promoters [PMID:16980615, PMID:20351289, PMID:33998598]. It binds DNA through its conserved DD1 domain and occupies FOX-like sequence elements genome-wide [PMID:12215533, PMID:20351289], while its conserved DS domain recruits the NCoR–HDAC1/2 and Sin3a corepressors to local chromatin [PMID:14525983, PMID:17182846, PMID:15280207]. Through this architecture DACH1 represses a broad set of effectors by direct physical association: it binds Smad4 to block TGF-β/Smad and AP-1 signaling [PMID:14525983], engages c-Jun to repress cyclin D1 and AP-1 targets [PMID:16980615, PMID:17182846], co-occupies estrogen-response elements with ERα [PMID:19605405], antagonizes FOXM1 occupancy [PMID:20351289], complexes with SNAI1 at the E-cadherin E-box to suppress EMT [PMID:25775416], and represses MMP9 by tethering HDAC1 to p65/c-Jun at NF-κB/AP-1 sites to reduce p65 acetylation [PMID:34772908]. In kidney tubule and podocyte cells DACH1 recruits the PTIP–H3K4Me3 complex to its bound promoters and lowers promoter H3K4Me3, repressing chemotactic and cell-cycle genes and protecting against fibrosis and diabetic injury [PMID:33998598, PMID:33998601]. DACH1 activity is integrated into the Six1–Eya–DACH network, where Eya phosphatase activity switches DACH1-containing complexes between repression and activation during organogenesis [PMID:12215533, PMID:14628042, PMID:11950062]. Its abundance is set post-translationally: HDAC4-mediated SUMOylation targets DACH1 for proteasomal degradation, and stabilized DACH1 co-represses ATF6 with NCOR to control hepatocyte insulin signaling and tPA/fibrinolysis [PMID:27239042, PMID:30504459]. DACH1 also acts through p53, inducing p53 Ser392 phosphorylation and mitochondrial translocation to drive SLC25A37-dependent ferroptosis [PMID:38437058]. Beyond transcription, DACH1 localizes to the base of primary cilia and is required for ciliogenesis [PMID:34022343], and Dach1/Dach2 are redundantly required for Müllerian duct development [PMID:18395837].","teleology":[{"year":2002,"claim":"Establishing how DACH1 contacts chromatin and cooperates within the Six-Eya-Dach module defined its biochemical mode of action as a context-switchable cofactor rather than an autonomous activator.","evidence":"GST pulldown, GAL4-reporter and chromatin-binding/CBP-recruitment assays mapping DNA binding to the DD1 domain; mammalian two-hybrid and GST pulldown defining direct Eya1-Dach1 interaction via disease mutations","pmids":["12215533","11950062"],"confidence":"High","gaps":["Does not resolve sequence specificity of DD1 DNA contacts","Eya1-Dach1 interaction tested with tagged/in vitro proteins, not endogenous complexes"]},{"year":2002,"claim":"Placing Dach1 downstream of FGF and antagonized by BMP positioned it as an integrator of growth-factor signaling in skeletal patterning.","evidence":"FGF/BMP4 bead implantation in mouse limb bud organ culture with AER removal and rescue","pmids":["12203718"],"confidence":"Medium","gaps":["Correlative expression changes without defined transcriptional mechanism","Does not establish direct regulators of the Dach1 locus"]},{"year":2003,"claim":"Identifying NCoR and Smad4 as DS-domain partners explained how DACH1 represses TGF-β/Smad and AP-1 signaling through corepressor recruitment.","evidence":"Endogenous reciprocal Co-IP, immunofluorescence co-localization, reporter assays, microarray of TGF-β targets, Smad4-null rescue","pmids":["14525983"],"confidence":"High","gaps":["Does not define DACH1 promoter occupancy genome-wide","Stoichiometry of the DACH1-NCoR-Smad4 complex unresolved"]},{"year":2003,"claim":"Demonstrating that Eya phosphatase activity flips Six1-DACH complexes between repression and activation established the regulatory switch governing DACH1 output during organogenesis.","evidence":"Mouse genetic epistasis (Six1/Eya mutants), Eya phosphatase enzymatic assays, reporter assays, Co-IP","pmids":["14628042"],"confidence":"High","gaps":["Direct phosphorylation substrate driving the switch not pinpointed","Whether DACH1 itself is dephosphorylated is not shown"]},{"year":2004,"claim":"Showing Dach1-Smad-Sin3a complexes repress BMP transcription extended the corepressor model into limb proximodistal patterning.","evidence":"Co-IP, in vivo chick limb gain/loss-of-function, reporter assays","pmids":["15280207"],"confidence":"High","gaps":["Mapped in chick ortholog","Direct DNA contacts at BMP target promoters not defined"]},{"year":2006,"claim":"Linking DACH1 to cyclin D1 repression via c-Jun and corepressor recruitment connected its molecular activity to growth suppression and tumor inhibition.","evidence":"ChIP, reporter assays, cyclin D1 and c-jun genetic rescue/excision, xenograft tumor growth, domain mutagenesis","pmids":["16980615","17182846"],"confidence":"High","gaps":["Whether DACH1 binds the cyclin D1 promoter directly or only via c-Jun not fully separated","Generality of the c-Jun delta-domain requirement across targets untested"]},{"year":2009,"claim":"Defining DACH1-ERα co-occupancy and the PELP1 coactivator switch showed how hormone signaling toggles DACH1 between repression and de-repression at estrogen-response elements.","evidence":"Reciprocal Co-IP, ChIP at endogenous ERE, proteomic identification of PELP1, domain mapping","pmids":["19605405"],"confidence":"High","gaps":["Mechanism of estrogen-driven corepressor disengagement not biochemically resolved","Direct vs indirect DACH1-PELP1 contact within ERα complex unclear"]},{"year":2010,"claim":"CAST and ChIP-seq defining a FOX-like DACH1 binding motif and FOXM1 antagonism established DACH1's intrinsic genomic targeting and a competition mechanism with forkhead factors.","evidence":"CAST, genome-wide ChIP-seq, promoter occupancy and colony formation assays","pmids":["20351289"],"confidence":"High","gaps":["Does not show whether DACH1 and FOXM1 compete for identical sites mechanistically","Affinity of direct DACH1-DNA binding not quantified"]},{"year":2011,"claim":"Identifying FGF2 repression placed DACH1 upstream of a tumor-initiating cell program in glioma.","evidence":"ChIP at FGF2 locus, inducible expression, bFGF rescue, xenograft","pmids":["21750150"],"confidence":"High","gaps":["Corepressor complex at the FGF2 locus not characterized","Relationship to the FGF-Dach1 developmental axis not addressed"]},{"year":2012,"claim":"Cell-cycle regulation in myeloid cells and a HOXA9-DACH1 leukemic complex broadened DACH1's roles to hematopoietic proliferation and context-dependent transcriptional promotion.","evidence":"Forced expression/shRNA with cell-cycle Western blots; endogenous HOXA9-DACH1 Co-IP, promoter occupancy of C/EBPα and GATA-1 at the DACH1 promoter","pmids":["22405764","22902925"],"confidence":"Medium","gaps":["Single-lab, Western-blot-based cell-cycle readouts","Mechanism by which DACH1 activates rather than represses with HOXA9 not defined"]},{"year":2013,"claim":"EMT suppression via YB-1 inactivation and Wnt/TCF-LEF inhibition expanded DACH1's antitumor reach to both cytoplasmic translational control and canonical Wnt output.","evidence":"Co-IP, TCF/LEF reporter assays, Western blot for c-Myc/cyclin D1, in vivo mammary and colorectal tumor models","pmids":["24335958","24149323"],"confidence":"Medium","gaps":["No direct DACH1 binding to Wnt pathway components shown","Cytoplasmic YB-1 mechanism not fully reconstituted"]},{"year":2015,"claim":"Defining a DACH1-SNAI1 complex at the E-cadherin E-box and CXCL5 repression mechanistically linked DACH1 to suppression of invasion and metastasis.","evidence":"Co-IP, ChIP at E-cadherin E-box, reporter assays, mouse metastasis model; gene expression screen with CXCL5 functional rescue","pmids":["25775416","25788272"],"confidence":"High","gaps":["Selectivity for SNAI1 over SNAI2 mechanism unexplained","Direct vs indirect CXCL5 promoter regulation not shown"]},{"year":2016,"claim":"Showing HDAC4-mediated SUMOylation controls DACH1 stability and that stabilized DACH1 co-represses ATF6 established post-translational control of DACH1 in hepatic metabolic disease.","evidence":"Co-IP, SUMOylation assay, HDAC4 translocation assay, hepatocyte shRNA and obese mouse rescue","pmids":["27239042"],"confidence":"High","gaps":["SUMO acceptor site on DACH1 not mapped","Direct DACH1 binding at the ATF6 promoter not demonstrated"]},{"year":2017,"claim":"Endothelial DACH1 control of CXCL12/CXCR4 migration under shear stress defined a flow-sensing role in coronary artery growth.","evidence":"Endothelial-specific Dach1 KO coronary morphometry, shear-stress culture, CXCR4 pharmacologic rescue","pmids":["28779009"],"confidence":"High","gaps":["How shear stress transcriptionally regulates DACH1 is unresolved","Whether DACH1 directly binds the CXCL12 promoter not shown"]},{"year":2018,"claim":"Mechanisms across fibrinolysis (ATF6-tPA), MMP9 repression via p65 deacetylation, and AMPK-driven DACH1 induction integrated DACH1 into NF-κB-dependent inflammatory and coagulation control.","evidence":"Hepatocyte-specific DACH1 KO with tPA readouts; DACH1-p65/c-Jun Co-IP, MMP9 ChIP, HDAC1 recruitment and p65 acetylation assays; metformin/AMPK siRNA epistasis with CXCL1 and MDSC assays","pmids":["30504459","34772908","29900050"],"confidence":"High","gaps":["AMPK-DACH1 connection (idx 20) is single-lab and indirect on the locus","How DACH1 abundance is sensed by NF-κB targets across tissues not unified"]},{"year":2019,"claim":"DACH1 suppression of Notch1 via c-Jun in endometrial carcinoma extended its antagonism of proliferative pathways to progestin resistance.","evidence":"Microarray, gain/loss-of-function Western blots for Notch1/c-Jun/Hes1, xenograft and progestin assays","pmids":["31215145"],"confidence":"Medium","gaps":["Pathway placement is expression-based without direct promoter binding","Single-lab study"]},{"year":2020,"claim":"A DACH1-SMAD4 association controlling BMP signaling in colorectal cancer stem cells showed context-dependent, pro-stemness DACH1 output.","evidence":"DACH1-SMAD4 Co-IP, CRISPR/shRNA, intestinal organoid and xenotransplant assays","pmids":["32512510"],"confidence":"Medium","gaps":["Opposing repressor vs pro-stemness roles context-dependence not mechanistically reconciled","Single-lab data"]},{"year":2021,"claim":"Identifying PTIP-H3K4Me3 complex recruitment as the chromatin mechanism by which DACH1 represses cell-cycle and chemotactic genes defined its epigenetic mode in kidney tubule and podocyte protection; a ciliary localization revealed a non-transcriptional function.","evidence":"Tubule- and podocyte-specific Dach1 KO/OE with disease models, DACH1 and H3K4Me3 ChIP, PTIP Co-IP, CRISPR editing of GWAS variants; siRNA knockdown with cilia imaging","pmids":["33998598","33998601","34022343"],"confidence":"High","gaps":["How DACH1 recruitment lowers rather than raises H3K4Me3 mechanistically unresolved","Ciliary role (idx 28) is single-study and mechanistically uncharacterized"]},{"year":2023,"claim":"A Dach1-c-Jun complex repressing the pro-apoptotic gene Bim defined a cytoprotective transcriptional mechanism in pulmonary fibrosis.","evidence":"DACH1-c-Jun Co-IP, ChIP at Bim promoter, lung-specific Dach1 OE/depletion mouse models","pmids":["36754276"],"confidence":"Medium","gaps":["Single-lab study","Corepressor machinery at the Bim promoter not defined"]},{"year":2024,"claim":"Demonstrating DACH1-driven p53 Ser392 phosphorylation, mitochondrial p53 translocation, and SLC25A37-dependent iron uptake established a transcription-independent ferroptosis axis controlled by DACH1 stability.","evidence":"CRISPR KO, DACH1-p53 Co-IP, p53 S392A mutagenesis abolishing binding, mitochondrial fractionation, hepatic fibrogenesis mouse model","pmids":["38437058"],"confidence":"High","gaps":["How DACH1 promotes p53 Ser392 phosphorylation (direct vs via a kinase) not resolved","Reconciliation with DACH1's nuclear corepressor roles unaddressed"]},{"year":null,"claim":"How DACH1 is switched between repressor, activator, and non-transcriptional (ciliary, mitochondrial-p53) functions in a tissue-specific manner, and the determinants of its complex selection, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking Eya-dependent switching, SUMO/ubiquitin stability control, and context-dependent partner choice","Structural basis of DD1 DNA binding and DS-domain corepressor docking undetermined","Endogenous DACH1 interactome under defined physiological states not comprehensively mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,3,4,6,14,18]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,6,8]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,5,8,22]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1,5,14]},{"term_id":"GO:0005929","term_label":"cilium","supporting_discovery_ids":[28]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[25]}],"pathway":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,4,6,14]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,9,21,22,27]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[3,16,21]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,9,29,30]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[25,26]}],"complexes":["Six1-Eya-DACH transcription complex","NCoR-HDAC1/2 corepressor complex","DACH1-PTIP/H3K4Me3 complex"],"partners":["NCOR1","SMAD4","JUN","ESR1","SNAI1","RELA","TP53","PAXIP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UI36","full_name":"Dachshund homolog 1","aliases":[],"length_aa":758,"mass_kda":78.6,"function":"Transcription factor that is involved in regulation of organogenesis. Seems to be a regulator of SIX1, SIX6 and probably SIX5. Corepression of precursor cell proliferation in myoblasts by SIX1 is switched to coactivation through recruitment of EYA3 to the SIX1-DACH1 complex. Transcriptional activation also seems to involve association of CREBBP. Seems to act as a corepressor of SIX6 in regulating proliferation by directly repressing cyclin-dependent kinase inhibitors, including the p27Kip1 promoter (By similarity). Inhibits TGF-beta signaling through interaction with SMAD4 and NCOR1. Binds to chromatin DNA via its DACHbox-N domain (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9UI36/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DACH1","classification":"Not Classified","n_dependent_lines":14,"n_total_lines":1208,"dependency_fraction":0.011589403973509934},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CD81","stoichiometry":4.0},{"gene":"PPM1G","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/DACH1","total_profiled":1310},"omim":[{"mim_id":"603803","title":"DACHSHUND FAMILY TRANSCRIPTION FACTOR 1; DACH1","url":"https://www.omim.org/entry/603803"},{"mim_id":"602085","title":"POLYDACTYLY, POSTAXIAL, TYPE A2; PAPA2","url":"https://www.omim.org/entry/602085"},{"mim_id":"300608","title":"DACHSHUND FAMILY TRANSCRIPTION FACTOR 2; DACH2","url":"https://www.omim.org/entry/300608"},{"mim_id":"112262","title":"BONE MORPHOGENETIC PROTEIN 4; BMP4","url":"https://www.omim.org/entry/112262"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear speckles","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"retina","ntpm":19.3}],"url":"https://www.proteinatlas.org/search/DACH1"},"hgnc":{"alias_symbol":[],"prev_symbol":["DACH"]},"alphafold":{"accession":"Q9UI36","domains":[{"cath_id":"3.10.260.20","chopping":"184-283","consensus_level":"medium","plddt":92.8592,"start":184,"end":283}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UI36","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UI36-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UI36-F1-predicted_aligned_error_v6.png","plddt_mean":57.16},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DACH1","jax_strain_url":"https://www.jax.org/strain/search?query=DACH1"},"sequence":{"accession":"Q9UI36","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UI36.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UI36/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UI36"}},"corpus_meta":[{"pmid":"14628042","id":"PMC_14628042","title":"Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/14628042","citation_count":535,"is_preprint":false},{"pmid":"14656016","id":"PMC_14656016","title":"DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.","date":"2003","source":"Clinical chemistry and laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/14656016","citation_count":192,"is_preprint":false},{"pmid":"17477914","id":"PMC_17477914","title":"Pax-Six-Eya-Dach network during amphioxus development: conservation in vitro but context specificity in vivo.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17477914","citation_count":136,"is_preprint":false},{"pmid":"14525983","id":"PMC_14525983","title":"DACH1 inhibits transforming growth factor-beta signaling through binding Smad4.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14525983","citation_count":126,"is_preprint":false},{"pmid":"12215533","id":"PMC_12215533","title":"Molecular interaction and synergistic activation of a promoter by Six, Eya, and Dach proteins mediated through CREB binding protein.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12215533","citation_count":124,"is_preprint":false},{"pmid":"16980615","id":"PMC_16980615","title":"DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16980615","citation_count":109,"is_preprint":false},{"pmid":"10502109","id":"PMC_10502109","title":"Mouse Dach, a homologue of Drosophila dachshund, is expressed in the developing retina, brain and limbs.","date":"1999","source":"Development genes and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/10502109","citation_count":92,"is_preprint":false},{"pmid":"29900050","id":"PMC_29900050","title":"Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis.","date":"2018","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/29900050","citation_count":86,"is_preprint":false},{"pmid":"28779009","id":"PMC_28779009","title":"DACH1 stimulates shear stress-guided endothelial cell migration and coronary artery growth through the CXCL12-CXCR4 signaling axis.","date":"2017","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/28779009","citation_count":80,"is_preprint":false},{"pmid":"24149323","id":"PMC_24149323","title":"Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer.","date":"2013","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/24149323","citation_count":79,"is_preprint":false},{"pmid":"25775416","id":"PMC_25775416","title":"DACH1 inhibits SNAI1-mediated epithelial-mesenchymal transition and represses breast carcinoma metastasis.","date":"2015","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/25775416","citation_count":78,"is_preprint":false},{"pmid":"11238885","id":"PMC_11238885","title":"Dach1 mutant mice bear no gross abnormalities in eye, limb, and brain development and exhibit postnatal lethality.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11238885","citation_count":78,"is_preprint":false},{"pmid":"26096807","id":"PMC_26096807","title":"The DACH/EYA/SIX gene network and its role in tumor initiation and progression.","date":"2015","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26096807","citation_count":75,"is_preprint":false},{"pmid":"24335958","id":"PMC_24335958","title":"Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation.","date":"2013","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24335958","citation_count":69,"is_preprint":false},{"pmid":"33998598","id":"PMC_33998598","title":"Transcriptome-wide association analysis identifies DACH1 as a kidney disease risk gene that contributes to fibrosis.","date":"2021","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/33998598","citation_count":67,"is_preprint":false},{"pmid":"17182846","id":"PMC_17182846","title":"Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth.","date":"2006","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/17182846","citation_count":66,"is_preprint":false},{"pmid":"23787902","id":"PMC_23787902","title":"Epigenetic silencing of DACH1 induces loss of transforming growth factor-β1 antiproliferative response in human hepatocellular carcinoma.","date":"2013","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23787902","citation_count":58,"is_preprint":false},{"pmid":"19605405","id":"PMC_19605405","title":"The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.","date":"2009","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19605405","citation_count":57,"is_preprint":false},{"pmid":"22788918","id":"PMC_22788918","title":"Revisiting [PtCl₂(cis-1,4-DACH)]: an underestimated antitumor drug with potential application to the treatment of oxaliplatin-refractory colorectal cancer.","date":"2012","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22788918","citation_count":57,"is_preprint":false},{"pmid":"20351289","id":"PMC_20351289","title":"Attenuation of Forkhead signaling by the retinal determination factor DACH1.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20351289","citation_count":55,"is_preprint":false},{"pmid":"25322986","id":"PMC_25322986","title":"DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells.","date":"2014","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25322986","citation_count":52,"is_preprint":false},{"pmid":"16024294","id":"PMC_16024294","title":"Pax6-dependence of Six3, Eya1 and Dach1 expression during lens and nasal placode induction.","date":"2005","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/16024294","citation_count":51,"is_preprint":false},{"pmid":"11804780","id":"PMC_11804780","title":"Dach1, a vertebrate homologue of Drosophila dachshund, is expressed in the developing eye and ear of both chick and mouse and is regulated independently of Pax and Eya genes.","date":"2002","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11804780","citation_count":51,"is_preprint":false},{"pmid":"12088753","id":"PMC_12088753","title":"Forebrain-specific promoter/enhancer D6 derived from the mouse Dach1 gene controls expression in neural stem cells.","date":"2002","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12088753","citation_count":50,"is_preprint":false},{"pmid":"31446800","id":"PMC_31446800","title":"Long Noncoding RNA-DACH1 (Dachshund Homolog 1) Regulates Cardiac Function by Inhibiting SERCA2a (Sarcoplasmic Reticulum Calcium ATPase 2a).","date":"2019","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/31446800","citation_count":49,"is_preprint":false},{"pmid":"19502783","id":"PMC_19502783","title":"Altered expression of DACH1 and cyclin D1 in endometrial cancer.","date":"2009","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/19502783","citation_count":46,"is_preprint":false},{"pmid":"25487617","id":"PMC_25487617","title":"The negative regulators of Wnt pathway-DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival.","date":"2014","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25487617","citation_count":46,"is_preprint":false},{"pmid":"28927149","id":"PMC_28927149","title":"MicroRNA-552 promotes tumor cell proliferation and migration by directly targeting DACH1 via the Wnt/β-catenin signaling pathway in colorectal cancer.","date":"2017","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/28927149","citation_count":45,"is_preprint":false},{"pmid":"27239042","id":"PMC_27239042","title":"Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin Resistance.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27239042","citation_count":44,"is_preprint":false},{"pmid":"36176913","id":"PMC_36176913","title":"LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation.","date":"2022","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/36176913","citation_count":44,"is_preprint":false},{"pmid":"11950062","id":"PMC_11950062","title":"Impaired interactions between mouse Eyal harboring mutations found in patients with branchio-oto-renal syndrome and Six, Dach, and G proteins.","date":"2002","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11950062","citation_count":43,"is_preprint":false},{"pmid":"25788272","id":"PMC_25788272","title":"DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25788272","citation_count":40,"is_preprint":false},{"pmid":"28387750","id":"PMC_28387750","title":"BMP6 Regulates Proliferation and Apoptosis of Human Sertoli Cells Via Smad2/3 and Cyclin D1 Pathway and DACH1 and TFAP2A Activation.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28387750","citation_count":39,"is_preprint":false},{"pmid":"25653720","id":"PMC_25653720","title":"MiR-217 Promotes Tumor Proliferation in Breast Cancer via Targeting DACH1.","date":"2015","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25653720","citation_count":38,"is_preprint":false},{"pmid":"33998601","id":"PMC_33998601","title":"DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity.","date":"2021","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/33998601","citation_count":37,"is_preprint":false},{"pmid":"21750150","id":"PMC_21750150","title":"Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cells.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21750150","citation_count":37,"is_preprint":false},{"pmid":"34383559","id":"PMC_34383559","title":"Dach1 Extends Artery Networks and Protects Against Cardiac Injury.","date":"2021","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/34383559","citation_count":37,"is_preprint":false},{"pmid":"18284193","id":"PMC_18284193","title":"Conformer distribution in (cis-1,4-DACH)bis(guanosine-5'-phosphate)platinum(II) adducts: a reliable model for DNA adducts of antitumoral cisplatin.","date":"2008","source":"Inorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18284193","citation_count":36,"is_preprint":false},{"pmid":"24912879","id":"PMC_24912879","title":"Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signalling.","date":"2014","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24912879","citation_count":35,"is_preprint":false},{"pmid":"28229139","id":"PMC_28229139","title":"PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features.","date":"2017","source":"Dalton transactions (Cambridge, England : 2003)","url":"https://pubmed.ncbi.nlm.nih.gov/28229139","citation_count":35,"is_preprint":false},{"pmid":"31247820","id":"PMC_31247820","title":"Cyclometalated Gold(III) Complexes Bearing DACH Ligands.","date":"2019","source":"Inorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31247820","citation_count":34,"is_preprint":false},{"pmid":"28659634","id":"PMC_28659634","title":"DACH1 suppresses breast cancer as a negative regulator of CD44.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28659634","citation_count":33,"is_preprint":false},{"pmid":"18395837","id":"PMC_18395837","title":"Mouse Dach1 and Dach2 are redundantly required for Müllerian duct development.","date":"2008","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/18395837","citation_count":33,"is_preprint":false},{"pmid":"11543628","id":"PMC_11543628","title":"DACH: genomic characterization, evaluation as a candidate for postaxial polydactyly type A2, and developmental expression pattern of the mouse homologue.","date":"2001","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/11543628","citation_count":33,"is_preprint":false},{"pmid":"15280207","id":"PMC_15280207","title":"Chick Dach1 interacts with the Smad complex and Sin3a to control AER formation and limb development along the proximodistal axis.","date":"2004","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15280207","citation_count":33,"is_preprint":false},{"pmid":"29333942","id":"PMC_29333942","title":"SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.","date":"2018","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29333942","citation_count":32,"is_preprint":false},{"pmid":"12898627","id":"PMC_12898627","title":"Tamoxifen derivatives for delivery of the antitumoral (DACH)Pt group: selective synthesis by McMurry coupling, and biochemical behaviour.","date":"2003","source":"Chembiochem : a European journal of chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/12898627","citation_count":32,"is_preprint":false},{"pmid":"24826817","id":"PMC_24826817","title":"Synthesis, crystal structure and antiproliferative activity of Cu(II) nalidixic acid-DACH conjugate: comparative in vitro DNA/RNA binding profile, cleavage activity and molecular docking studies.","date":"2014","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24826817","citation_count":31,"is_preprint":false},{"pmid":"20928895","id":"PMC_20928895","title":"A mechanistic approach for the DNA binding of chiral enantiomeric L- and D-tryptophan-derived metal complexes of 1,2-DACH: cleavage and antitumor activity.","date":"2010","source":"Chirality","url":"https://pubmed.ncbi.nlm.nih.gov/20928895","citation_count":31,"is_preprint":false},{"pmid":"30691681","id":"PMC_30691681","title":"Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network.","date":"2019","source":"Advances in cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30691681","citation_count":30,"is_preprint":false},{"pmid":"30504459","id":"PMC_30504459","title":"An ATF6-tPA pathway in hepatocytes contributes to systemic fibrinolysis and is repressed by DACH1.","date":"2018","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/30504459","citation_count":30,"is_preprint":false},{"pmid":"24743895","id":"PMC_24743895","title":"Silencing DACH1 promotes esophageal cancer growth by inhibiting TGF-β signaling.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24743895","citation_count":30,"is_preprint":false},{"pmid":"22405764","id":"PMC_22405764","title":"DACH1 regulates cell cycle progression of myeloid cells through the control of cyclin D, Cdk 4/6 and p21Cip1.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22405764","citation_count":29,"is_preprint":false},{"pmid":"9295871","id":"PMC_9295871","title":"[Oxaliplatin: the first DACH platinum in clinical practice].","date":"1997","source":"Bulletin du cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9295871","citation_count":29,"is_preprint":false},{"pmid":"24815057","id":"PMC_24815057","title":"Synthesis and characterization of new transition metal {Cu(II), Ni(II) and Co(II)} L-phenylalanine-DACH conjugate complexes: in vitro DNA binding, cleavage and molecular docking studies.","date":"2014","source":"Journal of photochemistry and photobiology. B, Biology","url":"https://pubmed.ncbi.nlm.nih.gov/24815057","citation_count":29,"is_preprint":false},{"pmid":"12203718","id":"PMC_12203718","title":"Fibroblast growth factor signaling regulates Dach1 expression during skeletal development.","date":"2002","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/12203718","citation_count":28,"is_preprint":false},{"pmid":"32512510","id":"PMC_32512510","title":"Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.","date":"2020","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/32512510","citation_count":27,"is_preprint":false},{"pmid":"25778865","id":"PMC_25778865","title":"Suppression of DACH1 promotes migration and invasion of colorectal cancer via activating TGF-β-mediated epithelial-mesenchymal transition.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25778865","citation_count":27,"is_preprint":false},{"pmid":"29498212","id":"PMC_29498212","title":"The transcription factor Dach1 is essential for podocyte function.","date":"2018","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29498212","citation_count":26,"is_preprint":false},{"pmid":"33077975","id":"PMC_33077975","title":"A new lymphoid-primed progenitor marked by Dach1 downregulation identified with single cell multi-omics.","date":"2020","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33077975","citation_count":25,"is_preprint":false},{"pmid":"25002963","id":"PMC_25002963","title":"Evolution of the Pax-Six-Eya-Dach network: the calcisponge case study.","date":"2014","source":"EvoDevo","url":"https://pubmed.ncbi.nlm.nih.gov/25002963","citation_count":24,"is_preprint":false},{"pmid":"23262432","id":"PMC_23262432","title":"Double homozygous missense mutations in DACH1 and BMP4 in a patient with bilateral cystic renal dysplasia.","date":"2012","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/23262432","citation_count":24,"is_preprint":false},{"pmid":"34772908","id":"PMC_34772908","title":"DACH1 inhibits breast cancer cell invasion and metastasis by down-regulating the transcription of matrix metalloproteinase 9.","date":"2021","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/34772908","citation_count":23,"is_preprint":false},{"pmid":"30720199","id":"PMC_30720199","title":"Long non-coding RNA HOTAIR regulates the development of non-small cell lung cancer through miR-217/DACH1 signaling pathway.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30720199","citation_count":23,"is_preprint":false},{"pmid":"25776071","id":"PMC_25776071","title":"DACH1, a zona glomerulosa selective gene in the human adrenal, activates transforming growth factor-β signaling and suppresses aldosterone secretion.","date":"2015","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/25776071","citation_count":23,"is_preprint":false},{"pmid":"12508235","id":"PMC_12508235","title":"Targeted disruption of mouse Dach1 results in postnatal lethality.","date":"2003","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/12508235","citation_count":23,"is_preprint":false},{"pmid":"27888806","id":"PMC_27888806","title":"Decreased DACH1 expression in glomerulopathy is associated with disease progression and severity.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27888806","citation_count":22,"is_preprint":false},{"pmid":"34022343","id":"PMC_34022343","title":"Biallelic variant in DACH1, encoding Dachshund Homolog 1, defines a novel candidate locus for recessive postaxial polydactyly type A.","date":"2021","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/34022343","citation_count":22,"is_preprint":false},{"pmid":"29688344","id":"PMC_29688344","title":"Dynamic and Cell-Specific DACH1 Expression in Human Neocortical and Striatal Development.","date":"2019","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/29688344","citation_count":20,"is_preprint":false},{"pmid":"28850769","id":"PMC_28850769","title":"Expression of genes and proteins of the pax-six-eya-dach network in the metamorphic sea urchin: Insights into development of the enigmatic echinoderm body plan and sensory structures.","date":"2017","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/28850769","citation_count":20,"is_preprint":false},{"pmid":"31215145","id":"PMC_31215145","title":"DACH1 suppresses epithelial to mesenchymal transition (EMT) through Notch1 pathway and reverses progestin resistance in endometrial carcinoma.","date":"2019","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31215145","citation_count":19,"is_preprint":false},{"pmid":"29307816","id":"PMC_29307816","title":"Neurotoxic effect of oxaliplatin: Comparison with its oxalate-free analogue cis-[PtII(1R,2R-DACH)(3-acetoxy-1,1-cyclobutanedicarboxylato)] (LLC-1402) in mice.","date":"2018","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29307816","citation_count":19,"is_preprint":false},{"pmid":"12932905","id":"PMC_12932905","title":"Synthesis, characterization and preliminary cytotoxicity assays of poly(ethylene glycol)-malonato-Pt-DACH conjugates.","date":"2003","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12932905","citation_count":18,"is_preprint":false},{"pmid":"32408786","id":"PMC_32408786","title":"DACH1, a novel target of miR-218, participates in the regulation of cell viability, apoptosis, inflammatory response, and epithelial-mesenchymal transition process in renal tubule cells treated by high-glucose.","date":"2020","source":"Renal failure","url":"https://pubmed.ncbi.nlm.nih.gov/32408786","citation_count":17,"is_preprint":false},{"pmid":"22902925","id":"PMC_22902925","title":"Regulation of HOXA9 activity by predominant expression of DACH1 against C/EBPα and GATA-1 in myeloid leukemia with MLL-AF9.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22902925","citation_count":17,"is_preprint":false},{"pmid":"24465431","id":"PMC_24465431","title":"Familial young-onset diabetes, pre-diabetes and cardiovascular disease are associated with genetic variants of DACH1 in Chinese.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24465431","citation_count":17,"is_preprint":false},{"pmid":"31405829","id":"PMC_31405829","title":"Role of Dach1 revealed using a novel inner ear-specific Dach1-knockdown mouse model.","date":"2019","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/31405829","citation_count":16,"is_preprint":false},{"pmid":"26810067","id":"PMC_26810067","title":"DACH1 inhibits the proliferation and invasion of lung adenocarcinoma through the downregulation of peroxiredoxin 3.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26810067","citation_count":16,"is_preprint":false},{"pmid":"38093319","id":"PMC_38093319","title":"S100A8/A9 as a risk factor for breast cancer negatively regulated by DACH1.","date":"2023","source":"Biomarker research","url":"https://pubmed.ncbi.nlm.nih.gov/38093319","citation_count":15,"is_preprint":false},{"pmid":"33378353","id":"PMC_33378353","title":"DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/33378353","citation_count":14,"is_preprint":false},{"pmid":"35492558","id":"PMC_35492558","title":"Evaluation of cytotoxic potential of structurally well-characterized RNA targeted ionic non-steroidal anti-inflammatory (NSAID) Cu(ii) & Zn(ii) DACH-mefenamato drug conjugates against human cancer cell lines.","date":"2019","source":"RSC advances","url":"https://pubmed.ncbi.nlm.nih.gov/35492558","citation_count":14,"is_preprint":false},{"pmid":"31806659","id":"PMC_31806659","title":"The PAX-SIX-EYA-DACH network modulates GATA-FOG function in fly hematopoiesis and human erythropoiesis.","date":"2020","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31806659","citation_count":13,"is_preprint":false},{"pmid":"36754276","id":"PMC_36754276","title":"Dach1 deficiency drives alveolar epithelium apoptosis in pulmonary fibrosis via modulating C-Jun/Bim activity.","date":"2023","source":"Translational research : the journal of laboratory and clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36754276","citation_count":11,"is_preprint":false},{"pmid":"26810463","id":"PMC_26810463","title":"Polymer nanoparticle delivery of dichloroacetate and DACH-Pt to enhance antitumor efficacy and lower systemic toxicity.","date":"2016","source":"Biomaterials science","url":"https://pubmed.ncbi.nlm.nih.gov/26810463","citation_count":11,"is_preprint":false},{"pmid":"35429108","id":"PMC_35429108","title":"The optimal use of chlormethine gel for mycosis fungoides: An expert consensus from Germany, Austria and Switzerland (DACH region).","date":"2022","source":"Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG","url":"https://pubmed.ncbi.nlm.nih.gov/35429108","citation_count":10,"is_preprint":false},{"pmid":"38437058","id":"PMC_38437058","title":"The cell fate regulator DACH1 modulates ferroptosis through affecting P53/SLC25A37 signaling in fibrotic disease.","date":"2024","source":"Hepatology communications","url":"https://pubmed.ncbi.nlm.nih.gov/38437058","citation_count":9,"is_preprint":false},{"pmid":"33463463","id":"PMC_33463463","title":"Role of DACH1 on Proliferation, Invasion, and Apoptosis in Human Lung Adenocarcinoma Cells.","date":"2021","source":"Current molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33463463","citation_count":9,"is_preprint":false},{"pmid":"27278537","id":"PMC_27278537","title":"Inhibition of DACH1 activity by short hairpin RNA represses cell proliferation and tumor invasion in pancreatic cancer.","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/27278537","citation_count":9,"is_preprint":false},{"pmid":"21558809","id":"PMC_21558809","title":"The type 1 insulin-like growth factor receptor and resistance to DACH1.","date":"2011","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/21558809","citation_count":9,"is_preprint":false},{"pmid":"29590536","id":"PMC_29590536","title":"Alteration of DACH1 methylation patterns in lung cancer contributes to cell proliferation and migration.","date":"2018","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/29590536","citation_count":8,"is_preprint":false},{"pmid":"30271168","id":"PMC_30271168","title":"DACH1 inhibits glioma invasion and tumor growth via the Wnt/catenin pathway.","date":"2018","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30271168","citation_count":8,"is_preprint":false},{"pmid":"33645454","id":"PMC_33645454","title":"New anticancer Pd and Pt complexes of tertamyl dithiocarbamate and DACH ligands against HT29 and Panc1 cell lines.","date":"2021","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/33645454","citation_count":8,"is_preprint":false},{"pmid":"30527681","id":"PMC_30527681","title":"MicroRNA-6807-3p promotes the tumorigenesis of glioma by targeting downstream DACH1.","date":"2018","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/30527681","citation_count":8,"is_preprint":false},{"pmid":"27289445","id":"PMC_27289445","title":"Synthesis and crystal structure elucidation of new copper(II)-based chemotherapeutic agent coupled with 1,2-DACH and orthovanillin: Validated by in vitro DNA/HSA binding profile and pBR322 cleavage pathway.","date":"2016","source":"Journal of photochemistry and photobiology. B, Biology","url":"https://pubmed.ncbi.nlm.nih.gov/27289445","citation_count":8,"is_preprint":false},{"pmid":"23458709","id":"PMC_23458709","title":"Focal cerebral ischemia induces the neurogenic potential of mouse Dach1-expressing cells in the dorsal part of the lateral ventricles.","date":"2013","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23458709","citation_count":8,"is_preprint":false},{"pmid":"37034893","id":"PMC_37034893","title":"Study of DACH1 Expression and its Epigenetic Regulators as Possible Breast Cancer-Related Biomarkers.","date":"2023","source":"Avicenna journal of medical biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/37034893","citation_count":7,"is_preprint":false},{"pmid":"30261897","id":"PMC_30261897","title":"Effect of DACH1 on proliferation and invasion of laryngeal squamous cell carcinoma.","date":"2018","source":"Head & face medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30261897","citation_count":7,"is_preprint":false},{"pmid":"32529465","id":"PMC_32529465","title":"MiR-645 regulates the proliferation and apoptosis of diffuse large B-cell lymphoma by targeting DACH1.","date":"2020","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/32529465","citation_count":7,"is_preprint":false},{"pmid":"35097124","id":"PMC_35097124","title":"The Function of circRNA-0047604 in Regulating the Tumor Suppressor Gene DACH1 in Breast Cancer.","date":"2022","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/35097124","citation_count":7,"is_preprint":false},{"pmid":"28206707","id":"PMC_28206707","title":"Probing the Interactions of Cytotoxic [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)] and Its PtIV Derivatives with Human Serum.","date":"2017","source":"ChemMedChem","url":"https://pubmed.ncbi.nlm.nih.gov/28206707","citation_count":7,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51643,"output_tokens":8397,"usd":0.140442,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17916,"output_tokens":6508,"usd":0.12614,"stage2_stop_reason":"end_turn"},"total_usd":0.266582,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"DACH1 binds endogenous NCoR and Smad4 in cultured cells and co-localizes with NCoR in nuclear dot-like structures; the DS domain of DACH1 is sufficient for NCoR binding at a Smad4-binding site, and DACH1 repression of TGF-β-induced AP-1 and Smad signaling requires the DS domain and Smad4.\",\n      \"method\": \"Co-immunoprecipitation of endogenous proteins, co-localization by immunofluorescence, gene reporter assays, microarray analysis of endogenous TGF-β target genes, Smad4-null cell rescue experiments\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP of endogenous proteins, co-localization, domain mapping, reporter assays, and epistasis in Smad4-null cells; multiple orthogonal methods in a single study\",\n      \"pmids\": [\"14525983\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"DACH1 (Dach) binds chromatin DNA directly through its conserved DD1 domain; it does not interact directly with Eya but synergizes with Eya to recruit CBP to chromatin, activating transcription via a Six-Eya-Dach complex.\",\n      \"method\": \"GST pulldown, GAL4-reporter transactivation assays, chromatin-binding assay with FLAG-Dach and GAL4-Eya fusion proteins, CBP recruitment measured on immobilized chromatin DNA template\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro chromatin-binding reconstitution, domain mapping (DD1), reporter assays, and CBP recruitment assay; multiple orthogonal methods in one study\",\n      \"pmids\": [\"12215533\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Eya phosphatase activity switches Six1-DACH complexes from transcriptional repression to activation; DACH participates in this switch by recruiting co-activators when Eya phosphatase is present, regulating precursor cell proliferation in organogenesis.\",\n      \"method\": \"Genetic interaction studies in mice (Six1 knockout, Eya compound mutants), transcriptional reporter assays, co-immunoprecipitation, Eya phosphatase activity assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — enzymatic assay establishing Eya phosphatase activity, genetic epistasis in mice, reporter assays; replicated across multiple organ systems in one rigorous study\",\n      \"pmids\": [\"14628042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DACH1 represses cyclin D1 transcription through a c-Jun DNA-binding partner; the DS domain recruits corepressors to local chromatin. Genetic deletion studies demonstrated a requirement for cyclin D1 in DACH1-mediated inhibition of DNA synthesis, and DACH1 inhibited breast tumor growth in mice.\",\n      \"method\": \"Chromatin immunoprecipitation, reporter assays, cyclin D1 knockout rescue experiments, colony formation/Matrigel growth assays, xenograft tumor growth in mice\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, genetic rescue with cyclin D1 deletion, in vivo tumor model, reporter assays; multiple orthogonal methods\",\n      \"pmids\": [\"16980615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DACH1 binds c-Jun and inhibits AP-1 transcriptional activity; it coprecipitates HDAC1, HDAC2, and NCoR and represses c-Jun target genes through the c-Jun delta domain in a manner requiring the conserved DS domain. An oncogenic v-Jun deleted of the delta domain is resistant to DACH1 repression.\",\n      \"method\": \"Co-immunoprecipitation, reporter assays, Cre-mediated c-jun excision in c-jun(fl/fl) cells (epistasis), c-jun rescue of DACH1 inhibition, domain deletion mutagenesis\",\n      \"journal\": \"Molecular Biology of the Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, genetic epistasis (Cre excision of c-jun), domain mutagenesis, and reporter assays; multiple orthogonal methods\",\n      \"pmids\": [\"17182846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DACH1 binds ERα by co-immunoprecipitation and co-associates with ERα at endogenous ER response elements by ChIP; it inhibits ERα transcriptional activity requiring the conserved DS domain. PELP1 was identified as a DACH1 C-terminus binding protein by proteomics; estrogen recruits ERα and disengages corepressors from DACH1, allowing PELP1 to serve as ERα coactivator.\",\n      \"method\": \"Co-immunoprecipitation/Western blot, chromatin immunoprecipitation, reporter assays, proteomic identification of PELP1, domain deletion mutagenesis\",\n      \"journal\": \"Cancer Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, ChIP at endogenous loci, proteomic identification of binding partner, domain mapping; multiple orthogonal methods in one study\",\n      \"pmids\": [\"19605405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DACH1 binds a DNA sequence resembling the FOX (Forkhead) binding site identified by CAST; genome-wide ChIP-seq confirmed DACH1 occupancy at FOX-like elements. DACH1 antagonized FOXM1 target gene expression and promoter occupancy in chromatin, blocking contact-independent growth.\",\n      \"method\": \"Cyclic amplification and selection of targets (CAST), in silico promoter analysis, ChIP coupled with high-throughput sequencing (ChIP-seq), promoter occupancy assays, colony formation assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the USA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — CAST to define binding sequence, genome-wide ChIP-seq, functional reporter and growth assays; multiple rigorous orthogonal methods\",\n      \"pmids\": [\"20351289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DACH1 suppresses EMT by repressing cytoplasmic translational induction of Snail through inactivating YB-1, and in the nucleus DACH1 antagonizes YB-1-mediated oncogenic transcriptional modules; DACH1 blocked YB-1-induced mammary tumor growth and EMT in mice.\",\n      \"method\": \"Co-immunoprecipitation, reporter assays, in vivo mammary tumor model, knockdown/overexpression studies\",\n      \"journal\": \"Cancer Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, in vivo tumor model, dual nuclear/cytoplasmic mechanism; single lab but multiple approaches\",\n      \"pmids\": [\"24335958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DACH1 physically interacts with SNAI1 (but not SNAI2) and forms a complex that binds the E-box on the E-cadherin promoter in an SNAI1-dependent manner; this complex inhibits SNAI1 transcriptional activity, resulting in E-cadherin activation and suppression of breast cancer EMT and metastasis.\",\n      \"method\": \"Co-immunoprecipitation, chromatin immunoprecipitation at E-cadherin E-box, reporter assays, loss/gain-of-function experiments, mouse metastasis model\",\n      \"journal\": \"Oncogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ChIP at endogenous promoter, reporter assays, in vivo metastasis model; multiple orthogonal methods\",\n      \"pmids\": [\"25775416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Chick Dach1 interacts with the Smad complex and Sin3a corepressor to repress BMP-mediated transcription; this antagonism regulates AER formation and limb proximodistal patterning.\",\n      \"method\": \"Co-immunoprecipitation (Dach1-Smad complex and Sin3a), in vivo gain/loss-of-function in chick limb, reporter assays\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, in vivo chick limb manipulations, reporter assays; ortholog paper with consistent domain function\",\n      \"pmids\": [\"15280207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In obesity, CaMKII phosphorylates HDAC4 blocking its nuclear translocation; this decreases HDAC4-mediated SUMOylation of DACH1, protecting DACH1 from proteasomal degradation. Stabilized DACH1 then co-represses ATF6 transcription together with NCOR, leading to PERK-TRB3 pathway activation and defective hepatocyte insulin signaling.\",\n      \"method\": \"Co-immunoprecipitation (DACH1-NCOR complex), SUMOylation assay, HDAC4 nuclear translocation assay, shRNA knockdown in liver (hepatocyte-specific), obese mouse model rescue experiments, Western blot\",\n      \"journal\": \"Cell Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple biochemical assays (Co-IP, SUMOylation, phosphorylation), in vivo liver-targeted shRNA rescue, mechanistic pathway placed by epistasis; rigorous multimethod study\",\n      \"pmids\": [\"27239042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DACH1 represses ATF6 transcription in hepatocytes (together with NCOR), controlling hepatocyte-derived tPA and basal plasma tPA/fibrinolytic activity; hepatocyte-DACH1-knockout mice show increased liver Plat, circulating tPA, and altered coagulation parameters reversed by hepatocyte Plat silencing.\",\n      \"method\": \"Hepatocyte-specific DACH1 knockout mice, co-repressor assays, liver Plat/tPA measurements, bleeding/thrombosis time assays, hepatocyte-ATF6 knockout comparison\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — liver-specific KO with multiple in vivo functional readouts, pathway epistasis (DACH1→ATF6→Plat), reversal by Plat silencing\",\n      \"pmids\": [\"30504459\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"DACH1 transcriptionally represses FGF2/bFGF; ChIP confirmed DACH1 binding at the FGF2 locus in serum-free glioma cells. Exogenous bFGF rescued spheroid-forming activity and tumorigenicity of DACH1-high glioma cells, placing DACH1 upstream of FGF2 in control of tumor-initiating cell activity.\",\n      \"method\": \"Chromatin immunoprecipitation, gene expression analysis, inducible DACH1 expression system (doxycycline-regulated), exogenous bFGF rescue, in vivo subcutaneous xenograft\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the USA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, inducible expression with dox, in vivo xenograft, bFGF rescue experiment; multiple orthogonal methods\",\n      \"pmids\": [\"21750150\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Endothelial DACH1 stimulates CXCL12 expression and endothelial cell polarization/migration against flow; loss of Dach1 in endothelium resulted in small coronary arteries and reduced CXCR4-dependent cell migration. High uniform laminar shear stress down-regulates DACH1 while low variable flow maintains it, linking flow quality to artery growth.\",\n      \"method\": \"Endothelial-specific Dach1 knockout mice (in vivo coronary artery morphometry), DACH1 overexpression under shear stress in culture, CXCL12/CXCR4 pharmacological inhibition rescue, flow cytometry, immunofluorescence\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — endothelial-specific KO with coronary phenotype, in vitro shear stress assay with pharmacologic rescue of CXCR4; multiple orthogonal methods\",\n      \"pmids\": [\"28779009\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DACH1 controls kidney tubule cell-cycle and myeloid chemotactic factor expression; tubule-specific Dach1 deletion caused more severe renal fibrosis in multiple injury models, while overexpression was protective. DACH1 interacts with PTIP (a component of the H3K4Me3 complex) and recruits it to DACH1-bound promoters, repressing target gene transcription and reducing promoter H3K4Me3 levels.\",\n      \"method\": \"Tubule-specific Dach1 KO and overexpression mouse models, single-cell RNA-seq, chromatin immunoprecipitation (ChIP for DACH1 and H3K4Me3), CRISPR-Cas9 gene editing of GWAS risk variants, in silico promoter analysis, PTIP co-immunoprecipitation\",\n      \"journal\": \"The Journal of Clinical Investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — tissue-specific KO and OE with functional rescue, ChIP for DACH1 binding and H3K4Me3, Co-IP of PTIP-DACH1, CRISPR editing; multiple orthogonal rigorous methods\",\n      \"pmids\": [\"33998598\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Podocyte-specific DACH1 interacts with PTIP (an H3K4Me3 complex component) and recruits it to promoter-binding sites, repressing transcription and reducing H3K4Me3 at target promoters; DACH1 knockdown combined with hyperglycemia triggers target gene upregulation and increased promoter H3K4Me3. Podocyte-specific Dach1 KO mice develop accelerated injury after diabetes onset while DACH1 augmentation is protective.\",\n      \"method\": \"Podocyte-specific Dach1 KO and overexpression mice, RNA-seq, ChIP (H3K4Me3), Co-IP of PTIP-DACH1, high-throughput in silico promoter analysis, diabetic kidney disease models\",\n      \"journal\": \"The Journal of Clinical Investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — cell-type specific KO and OE with disease phenotype, ChIP, Co-IP, multi-model validation; highly rigorous\",\n      \"pmids\": [\"33998601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DACH1 regulates cell cycle progression in myeloid progenitor cells: forced DACH1 expression induced p27(Kip1) and repressed p21(Cip1), increased cyclin D1/D3/F and Cdk 1/4/6 expression; DACH1 knockdown blocked HL-60 cell cycle progression through decrease of cyclins/Cdks, increase of p21(Cip1), and reduced Rb phosphorylation.\",\n      \"method\": \"Forced expression and shRNA knockdown in myeloid progenitor/HL-60 cells, Western blot for cell cycle proteins, Rb phosphorylation assay\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — gain and loss-of-function with consistent downstream readouts; single lab, Western blot-based\",\n      \"pmids\": [\"22405764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"An endogenous HOXA9-DACH1 complex is mediated by the carboxyl terminus of DACH1 in t(9;11) leukemia cells; DACH1 has stronger transcription-promoting activity with HOXA9 than does PBX2 with HOXA9; C/EBPα and GATA-1 directly bind the DACH1 promoter and act as transcriptional suppressors of DACH1.\",\n      \"method\": \"Co-immunoprecipitation of endogenous HOXA9-DACH1, qRT-PCR, chromatin occupancy of C/EBPα/GATA-1 at DACH1 promoter, domain mapping (DACH1 carboxyl terminus), ectopic expression experiments\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — endogenous Co-IP, promoter-binding evidence, functional expression experiments; single lab\",\n      \"pmids\": [\"22902925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DACH1 inhibits the transcription of MMP9 by interacting with p65 and c-Jun at NF-κB and AP-1 binding sites in the MMP9 promoter; DACH1-p65 association promotes recruitment of HDAC1 to the NF-κB site, reducing p65 acetylation and transcriptional activity, thereby decreasing MMP9 levels and breast cancer cell invasion.\",\n      \"method\": \"Co-immunoprecipitation (DACH1-p65, DACH1-c-Jun), chromatin immunoprecipitation at MMP9 promoter NF-κB/AP-1 sites, HDAC1 recruitment assay, p65 acetylation assay, invasion assays\",\n      \"journal\": \"Cell Death Discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple Co-IPs, ChIP at endogenous MMP9 promoter, HDAC1 recruitment, p65 acetylation; multiple orthogonal methods in one study\",\n      \"pmids\": [\"34772908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DACH1 suppresses CXCL5 expression in lung adenocarcinoma cells; there is an inverse correlation between DACH1 mRNA and CXCL5 in lung cancer cell lines and human NSCLC tissues, and functional rescue showed DACH1 effects on invasion are dependent in part on CXCL5 suppression.\",\n      \"method\": \"Unbiased gene expression screen, qPCR correlation analysis, functional rescue with CXCL5 overexpression, in vitro migration/invasion assays, in vivo tumor xenograft\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — unbiased screen followed by functional CXCL5 rescue; single lab\",\n      \"pmids\": [\"25788272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Metformin enhances AMPK phosphorylation, which induces DACH1 expression leading to NF-κB inhibition and reduced CXCL1 secretion; DACH1 knockdown blocked the effect of metformin on MDSC chemotaxis, placing DACH1 downstream of AMPK and upstream of CXCL1/NF-κB in this pathway.\",\n      \"method\": \"Metformin treatment with AMPK/DACH1 knockdown (siRNA epistasis), CXCL1 secretion assay, MDSC migration assay, tumor xenograft in mice with adoptive transfer\",\n      \"journal\": \"Oncoimmunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway epistasis by siRNA knockdown, in vivo xenograft with adoptive transfer; single lab\",\n      \"pmids\": [\"29900050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DACH1 suppresses colorectal cancer growth by inhibiting Wnt/TCF-LEF signaling; re-expression of DACH1 reduced TCF/LEF luciferase reporter activity and suppressed Wnt downstream targets c-Myc and cyclin D1. DACH1 re-expression induced G2/M phase arrest and sensitized cells to docetaxel.\",\n      \"method\": \"TCF/LEF reporter assay, Western blot for c-Myc/cyclin D1, cell cycle analysis (flow cytometry), xenograft tumor model, 5-aza-dC demethylation/re-expression\",\n      \"journal\": \"Epigenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — reporter assays and Western blot with in vivo xenograft; single lab, no direct binding to Wnt components demonstrated\",\n      \"pmids\": [\"24149323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DACH1 promotes colorectal cancer stem cell properties through suppression of BMP signaling via SMAD4; co-immunoprecipitation demonstrated association between DACH1 and SMAD4; shRNA-mediated DACH1 suppression reduced organoid formation and tumor growth, while DACH1 overexpression stimulated colonsphere formation in the context of dysregulated BMP signaling.\",\n      \"method\": \"Co-immunoprecipitation (DACH1-SMAD4), CRISPR/Cas9 KO and shRNA knockdown, intestinal organoid model, microarray data analysis, xenotransplant\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP of DACH1-SMAD4, organoid and xenotransplant functional readouts; single lab\",\n      \"pmids\": [\"32512510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DACH1 and SIX1 co-localize in hepatocellular carcinoma cells; immunoprecipitation shows DACH1 (Flag-tagged) pulls down p53 and SIX1, while SIX1 (His-tagged) pulls down DACH1 but not p53 (indicating SIX1-p53 regulation is indirect through DACH1). DACH1 overexpression suppresses tumorigenesis by up-regulating p53.\",\n      \"method\": \"Immunoprecipitation (tagged proteins), immunofluorescence co-localization, colony formation assay, nude mice xenograft, Western blot for p53\",\n      \"journal\": \"Cancer Biology & Therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP with tagged proteins, consistent in vivo xenograft data; single lab, tagged (not endogenous) protein interaction\",\n      \"pmids\": [\"29333942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Mutations in the EYA domain of Eya1 associated with BOR syndrome (S486P and L504R) show defective interactions with Dach1, G proteins, and some Six proteins by GST pulldown and mammalian two-hybrid assays, implicating direct Eya1-Dach1 protein interaction in normal development.\",\n      \"method\": \"Mammalian two-hybrid assay, GST pulldown, trypsin/V8 protease digestion pattern analysis, transcriptional activation assay (myogenin promoter)\",\n      \"journal\": \"Journal of Human Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — GST pulldown and mammalian two-hybrid showing direct Eya1-Dach1 interaction; disease-linked mutations clarify biological relevance\",\n      \"pmids\": [\"11950062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DACH1 modulates ferroptosis via the P53/SLC25A37 pathway: ferroptosis inducers increase DACH1 protein by suppressing ubiquitin-proteasome degradation; DACH1 induces p53 phosphorylation at serine 392, causing mitochondrial translocation of p53; mitochondrial p53 binds SLC25A37, enhancing mitochondrial iron uptake and triggering ferroptosis. Mutation of serine 392 prevents DACH1-p53 binding and ferroptosis.\",\n      \"method\": \"CRISPR-Cas9 DACH1 knockout in hepatic stellate cells, Co-immunoprecipitation (DACH1-p53), pulldown assays, p53 S392A mutagenesis, mitochondrial fractionation, mouse model of hepatic fibrogenesis with HSC-specific knockdowns\",\n      \"journal\": \"Hepatology Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — CRISPR KO, site-directed mutagenesis (S392A) abolishing DACH1-p53 interaction, Co-IP, subcellular fractionation, in vivo mouse model; multiple orthogonal methods\",\n      \"pmids\": [\"38437058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Dach1 combined with c-Jun protooncogene selectively binds the promoter of the pro-apoptotic gene Bim, repressing its expression and protecting type II alveolar epithelial cells from apoptosis in pulmonary fibrosis.\",\n      \"method\": \"Co-immunoprecipitation (DACH1-c-Jun), ChIP at Bim promoter, lung-specific Dach1 overexpression and Dach1 depletion mouse models (BLM-induced PF), in vitro apoptosis assay\",\n      \"journal\": \"Translational Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP and ChIP combined with in vivo lung-specific models; single lab\",\n      \"pmids\": [\"36754276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DACH1 suppresses EMT and progestin resistance in endometrial carcinoma through Notch1 pathway inhibition via c-Jun; DACH1 overexpression decreased c-Jun, Notch1, and Hes1 expression, and reversed progestin resistance both in vitro and in a xenograft model.\",\n      \"method\": \"Microarray analysis, gain/loss-of-function with Western blot for Notch1/c-Jun/Hes1, xenograft model, progestin sensitivity assays\",\n      \"journal\": \"Cancer Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Western blot pathway analysis, in vivo xenograft; pathway placement by expression/OE/KD; single lab\",\n      \"pmids\": [\"31215145\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"siRNA-mediated depletion of DACH1 disrupted primary cilia formation and function in human cells; DACH1 protein localizes to the base of primary cilia as shown by advanced microscopy, revealing a role for DACH1 in ciliogenesis.\",\n      \"method\": \"siRNA knockdown of DACH1, advanced microscopy imaging (localization at base of cilia), cilia functional assays\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Weak — direct localization by imaging and loss-of-function for ciliogenesis; single study, single lab\",\n      \"pmids\": [\"34022343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Dach1 and Dach2 are redundantly required for Müllerian duct development; Dach1/2 double mutants show severely disrupted female reproductive tract with abnormal Lim1 and Wnt7a expression in the Müllerian duct, while Wolffian duct development is unaffected.\",\n      \"method\": \"Dach1/Dach2 double homozygous knockout mice, in situ hybridization for Lim1 and Wnt7a in Müllerian duct\",\n      \"journal\": \"Genesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic double KO with specific reproductive tract phenotype and downstream target analysis; replicates Drosophila dac FRT phenotype\",\n      \"pmids\": [\"18395837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Fibroblast growth factors (FGF1, 2, 8, 9 but not FGF10) up-regulate Dach1 expression in mouse limb buds while BMP4 down-regulates it; FGF4 or FGF8 can substitute for the apical ectodermal ridge in maintaining Dach1 expression, placing Dach1 as a downstream target of FGF signaling in skeletal development.\",\n      \"method\": \"FGF-bead implantation in ex vivo mouse limb bud organ culture, BMP4/Shh bead implantation, AER removal with FGF rescue, immunolocalization of Dach1 with Runx2 and CDK inhibitors\",\n      \"journal\": \"Developmental Dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — bead implantation in organ culture with multiple growth factors tested; consistent FGF-Dach1 epistasis\",\n      \"pmids\": [\"12203718\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DACH1 is a transcriptional corepressor/cofactor that lacks autonomous DNA-binding through a sequence-specific domain (the DD1 domain binds chromatin/DNA) and functions through context-dependent complexes: it represses TGF-β/Smad, AP-1 (c-Jun), ERα, FOXM1, NF-κB, Wnt/TCF-LEF, Notch1, BMP/Smad, and Bim transcription by recruiting corepressors (NCoR, HDAC1/2, Sin3a) and by interacting directly with pathway effectors (Smad4, c-Jun, ERα, YB-1, p53, PTIP-H3K4Me3 complex), while its activity as a repressor or activator is switched by Eya phosphatase activity within the Six1-Eya-DACH network; post-translational regulation by HDAC4-mediated SUMOylation and ubiquitin-proteasome degradation controls DACH1 protein stability in metabolic and fibrotic contexts.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DACH1 is a chromatin-associated transcriptional corepressor that constrains proliferation and cell-fate transitions across development, cancer, and tissue injury by docking onto pathway-specific effectors and delivering corepressor machinery to target promoters [#3, #6, #14]. It binds DNA through its conserved DD1 domain and occupies FOX-like sequence elements genome-wide [#1, #6], while its conserved DS domain recruits the NCoR–HDAC1/2 and Sin3a corepressors to local chromatin [#0, #4, #9]. Through this architecture DACH1 represses a broad set of effectors by direct physical association: it binds Smad4 to block TGF-β/Smad and AP-1 signaling [#0], engages c-Jun to repress cyclin D1 and AP-1 targets [#3, #4], co-occupies estrogen-response elements with ERα [#5], antagonizes FOXM1 occupancy [#6], complexes with SNAI1 at the E-cadherin E-box to suppress EMT [#8], and represses MMP9 by tethering HDAC1 to p65/c-Jun at NF-κB/AP-1 sites to reduce p65 acetylation [#18]. In kidney tubule and podocyte cells DACH1 recruits the PTIP–H3K4Me3 complex to its bound promoters and lowers promoter H3K4Me3, repressing chemotactic and cell-cycle genes and protecting against fibrosis and diabetic injury [#14, #15]. DACH1 activity is integrated into the Six1–Eya–DACH network, where Eya phosphatase activity switches DACH1-containing complexes between repression and activation during organogenesis [#1, #2, #24]. Its abundance is set post-translationally: HDAC4-mediated SUMOylation targets DACH1 for proteasomal degradation, and stabilized DACH1 co-represses ATF6 with NCOR to control hepatocyte insulin signaling and tPA/fibrinolysis [#10, #11]. DACH1 also acts through p53, inducing p53 Ser392 phosphorylation and mitochondrial translocation to drive SLC25A37-dependent ferroptosis [#25]. Beyond transcription, DACH1 localizes to the base of primary cilia and is required for ciliogenesis [#28], and Dach1/Dach2 are redundantly required for Müllerian duct development [#29].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing how DACH1 contacts chromatin and cooperates within the Six-Eya-Dach module defined its biochemical mode of action as a context-switchable cofactor rather than an autonomous activator.\",\n      \"evidence\": \"GST pulldown, GAL4-reporter and chromatin-binding/CBP-recruitment assays mapping DNA binding to the DD1 domain; mammalian two-hybrid and GST pulldown defining direct Eya1-Dach1 interaction via disease mutations\",\n      \"pmids\": [\"12215533\", \"11950062\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not resolve sequence specificity of DD1 DNA contacts\", \"Eya1-Dach1 interaction tested with tagged/in vitro proteins, not endogenous complexes\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Placing Dach1 downstream of FGF and antagonized by BMP positioned it as an integrator of growth-factor signaling in skeletal patterning.\",\n      \"evidence\": \"FGF/BMP4 bead implantation in mouse limb bud organ culture with AER removal and rescue\",\n      \"pmids\": [\"12203718\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Correlative expression changes without defined transcriptional mechanism\", \"Does not establish direct regulators of the Dach1 locus\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identifying NCoR and Smad4 as DS-domain partners explained how DACH1 represses TGF-β/Smad and AP-1 signaling through corepressor recruitment.\",\n      \"evidence\": \"Endogenous reciprocal Co-IP, immunofluorescence co-localization, reporter assays, microarray of TGF-β targets, Smad4-null rescue\",\n      \"pmids\": [\"14525983\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not define DACH1 promoter occupancy genome-wide\", \"Stoichiometry of the DACH1-NCoR-Smad4 complex unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrating that Eya phosphatase activity flips Six1-DACH complexes between repression and activation established the regulatory switch governing DACH1 output during organogenesis.\",\n      \"evidence\": \"Mouse genetic epistasis (Six1/Eya mutants), Eya phosphatase enzymatic assays, reporter assays, Co-IP\",\n      \"pmids\": [\"14628042\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct phosphorylation substrate driving the switch not pinpointed\", \"Whether DACH1 itself is dephosphorylated is not shown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showing Dach1-Smad-Sin3a complexes repress BMP transcription extended the corepressor model into limb proximodistal patterning.\",\n      \"evidence\": \"Co-IP, in vivo chick limb gain/loss-of-function, reporter assays\",\n      \"pmids\": [\"15280207\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mapped in chick ortholog\", \"Direct DNA contacts at BMP target promoters not defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Linking DACH1 to cyclin D1 repression via c-Jun and corepressor recruitment connected its molecular activity to growth suppression and tumor inhibition.\",\n      \"evidence\": \"ChIP, reporter assays, cyclin D1 and c-jun genetic rescue/excision, xenograft tumor growth, domain mutagenesis\",\n      \"pmids\": [\"16980615\", \"17182846\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DACH1 binds the cyclin D1 promoter directly or only via c-Jun not fully separated\", \"Generality of the c-Jun delta-domain requirement across targets untested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defining DACH1-ERα co-occupancy and the PELP1 coactivator switch showed how hormone signaling toggles DACH1 between repression and de-repression at estrogen-response elements.\",\n      \"evidence\": \"Reciprocal Co-IP, ChIP at endogenous ERE, proteomic identification of PELP1, domain mapping\",\n      \"pmids\": [\"19605405\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of estrogen-driven corepressor disengagement not biochemically resolved\", \"Direct vs indirect DACH1-PELP1 contact within ERα complex unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"CAST and ChIP-seq defining a FOX-like DACH1 binding motif and FOXM1 antagonism established DACH1's intrinsic genomic targeting and a competition mechanism with forkhead factors.\",\n      \"evidence\": \"CAST, genome-wide ChIP-seq, promoter occupancy and colony formation assays\",\n      \"pmids\": [\"20351289\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not show whether DACH1 and FOXM1 compete for identical sites mechanistically\", \"Affinity of direct DACH1-DNA binding not quantified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identifying FGF2 repression placed DACH1 upstream of a tumor-initiating cell program in glioma.\",\n      \"evidence\": \"ChIP at FGF2 locus, inducible expression, bFGF rescue, xenograft\",\n      \"pmids\": [\"21750150\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Corepressor complex at the FGF2 locus not characterized\", \"Relationship to the FGF-Dach1 developmental axis not addressed\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Cell-cycle regulation in myeloid cells and a HOXA9-DACH1 leukemic complex broadened DACH1's roles to hematopoietic proliferation and context-dependent transcriptional promotion.\",\n      \"evidence\": \"Forced expression/shRNA with cell-cycle Western blots; endogenous HOXA9-DACH1 Co-IP, promoter occupancy of C/EBPα and GATA-1 at the DACH1 promoter\",\n      \"pmids\": [\"22405764\", \"22902925\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab, Western-blot-based cell-cycle readouts\", \"Mechanism by which DACH1 activates rather than represses with HOXA9 not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"EMT suppression via YB-1 inactivation and Wnt/TCF-LEF inhibition expanded DACH1's antitumor reach to both cytoplasmic translational control and canonical Wnt output.\",\n      \"evidence\": \"Co-IP, TCF/LEF reporter assays, Western blot for c-Myc/cyclin D1, in vivo mammary and colorectal tumor models\",\n      \"pmids\": [\"24335958\", \"24149323\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct DACH1 binding to Wnt pathway components shown\", \"Cytoplasmic YB-1 mechanism not fully reconstituted\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defining a DACH1-SNAI1 complex at the E-cadherin E-box and CXCL5 repression mechanistically linked DACH1 to suppression of invasion and metastasis.\",\n      \"evidence\": \"Co-IP, ChIP at E-cadherin E-box, reporter assays, mouse metastasis model; gene expression screen with CXCL5 functional rescue\",\n      \"pmids\": [\"25775416\", \"25788272\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Selectivity for SNAI1 over SNAI2 mechanism unexplained\", \"Direct vs indirect CXCL5 promoter regulation not shown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showing HDAC4-mediated SUMOylation controls DACH1 stability and that stabilized DACH1 co-represses ATF6 established post-translational control of DACH1 in hepatic metabolic disease.\",\n      \"evidence\": \"Co-IP, SUMOylation assay, HDAC4 translocation assay, hepatocyte shRNA and obese mouse rescue\",\n      \"pmids\": [\"27239042\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"SUMO acceptor site on DACH1 not mapped\", \"Direct DACH1 binding at the ATF6 promoter not demonstrated\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Endothelial DACH1 control of CXCL12/CXCR4 migration under shear stress defined a flow-sensing role in coronary artery growth.\",\n      \"evidence\": \"Endothelial-specific Dach1 KO coronary morphometry, shear-stress culture, CXCR4 pharmacologic rescue\",\n      \"pmids\": [\"28779009\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How shear stress transcriptionally regulates DACH1 is unresolved\", \"Whether DACH1 directly binds the CXCL12 promoter not shown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Mechanisms across fibrinolysis (ATF6-tPA), MMP9 repression via p65 deacetylation, and AMPK-driven DACH1 induction integrated DACH1 into NF-κB-dependent inflammatory and coagulation control.\",\n      \"evidence\": \"Hepatocyte-specific DACH1 KO with tPA readouts; DACH1-p65/c-Jun Co-IP, MMP9 ChIP, HDAC1 recruitment and p65 acetylation assays; metformin/AMPK siRNA epistasis with CXCL1 and MDSC assays\",\n      \"pmids\": [\"30504459\", \"34772908\", \"29900050\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"AMPK-DACH1 connection (idx 20) is single-lab and indirect on the locus\", \"How DACH1 abundance is sensed by NF-κB targets across tissues not unified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"DACH1 suppression of Notch1 via c-Jun in endometrial carcinoma extended its antagonism of proliferative pathways to progestin resistance.\",\n      \"evidence\": \"Microarray, gain/loss-of-function Western blots for Notch1/c-Jun/Hes1, xenograft and progestin assays\",\n      \"pmids\": [\"31215145\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Pathway placement is expression-based without direct promoter binding\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"A DACH1-SMAD4 association controlling BMP signaling in colorectal cancer stem cells showed context-dependent, pro-stemness DACH1 output.\",\n      \"evidence\": \"DACH1-SMAD4 Co-IP, CRISPR/shRNA, intestinal organoid and xenotransplant assays\",\n      \"pmids\": [\"32512510\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Opposing repressor vs pro-stemness roles context-dependence not mechanistically reconciled\", \"Single-lab data\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identifying PTIP-H3K4Me3 complex recruitment as the chromatin mechanism by which DACH1 represses cell-cycle and chemotactic genes defined its epigenetic mode in kidney tubule and podocyte protection; a ciliary localization revealed a non-transcriptional function.\",\n      \"evidence\": \"Tubule- and podocyte-specific Dach1 KO/OE with disease models, DACH1 and H3K4Me3 ChIP, PTIP Co-IP, CRISPR editing of GWAS variants; siRNA knockdown with cilia imaging\",\n      \"pmids\": [\"33998598\", \"33998601\", \"34022343\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How DACH1 recruitment lowers rather than raises H3K4Me3 mechanistically unresolved\", \"Ciliary role (idx 28) is single-study and mechanistically uncharacterized\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"A Dach1-c-Jun complex repressing the pro-apoptotic gene Bim defined a cytoprotective transcriptional mechanism in pulmonary fibrosis.\",\n      \"evidence\": \"DACH1-c-Jun Co-IP, ChIP at Bim promoter, lung-specific Dach1 OE/depletion mouse models\",\n      \"pmids\": [\"36754276\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study\", \"Corepressor machinery at the Bim promoter not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrating DACH1-driven p53 Ser392 phosphorylation, mitochondrial p53 translocation, and SLC25A37-dependent iron uptake established a transcription-independent ferroptosis axis controlled by DACH1 stability.\",\n      \"evidence\": \"CRISPR KO, DACH1-p53 Co-IP, p53 S392A mutagenesis abolishing binding, mitochondrial fractionation, hepatic fibrogenesis mouse model\",\n      \"pmids\": [\"38437058\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How DACH1 promotes p53 Ser392 phosphorylation (direct vs via a kinase) not resolved\", \"Reconciliation with DACH1's nuclear corepressor roles unaddressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How DACH1 is switched between repressor, activator, and non-transcriptional (ciliary, mitochondrial-p53) functions in a tissue-specific manner, and the determinants of its complex selection, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking Eya-dependent switching, SUMO/ubiquitin stability control, and context-dependent partner choice\", \"Structural basis of DD1 DNA binding and DS-domain corepressor docking undetermined\", \"Endogenous DACH1 interactome under defined physiological states not comprehensively mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 3, 4, 6, 14, 18]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 6, 8]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 5, 8, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1, 5, 14]},\n      {\"term_id\": \"GO:0005929\", \"supporting_discovery_ids\": [28]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [25]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 4, 6, 14]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 9, 21, 22, 27]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [3, 16, 21]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 9, 29, 30]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [25, 26]}\n    ],\n    \"complexes\": [\n      \"Six1-Eya-DACH transcription complex\",\n      \"NCoR-HDAC1/2 corepressor complex\",\n      \"DACH1-PTIP/H3K4Me3 complex\"\n    ],\n    \"partners\": [\n      \"NCOR1\",\n      \"SMAD4\",\n      \"JUN\",\n      \"ESR1\",\n      \"SNAI1\",\n      \"RELA\",\n      \"TP53\",\n      \"PAXIP1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}